Atorvastatin API Market Key Leaders, Emerging Technology, future 2027

 

The Global Atorvastatin API Market is estimated to be valued at USD 4,25,804.16 thousand and is expected to register a CAGR of 3.34% during the forecast period.

The hypercholesterolemia segment is expected to lead the market and register a substantial CAGR to reach USD 2,10,753.23 thousand by the end of 2023. High prevalence of hypercholesterolemia is expected to drive the market growth. Additionally, the segment is projected to exhibit the highest CAGR of 4.09% from 2018 to 2023.

North America accounted for the largest market share of 40.64% in 2017, and the regional market is projected to register a CAGR of 3.10% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Chinese market is projected to exhibit the highest growth rate of 5.86% during the forecast period from 2018 to 2023.



Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7885

Segment Analysis

The hypercholesterolemia segment is expected to lead the market and register a substantial CAGR to reach USD 2,10,753.23 thousand by the end of 2023. High prevalence of hypercholesterolemia is expected to drive the market growth. Additionally, the segment is projected to exhibit the highest CAGR of 4.09% from 2018 to 2023.

Market Players

Market Research Future (MRFR) recognizes Teva Pharmaceutical Industries Ltd (Israel), Jubilant Life Sciences Ltd (India), Dr. Reddy’s Laboratories Ltd (India), Sun Pharmaceutical Industries Ltd (India), Ind-Swift Labs Ltd (India), Morepen Laboratories Ltd (India), Zhejiang Hisun Pharmaceutical Co Ltd (China), Anuh Pharma Ltd (India), Centrient Pharmaceuticals (The Netherlands) and Cadila Pharmaceuticals (India) as the key players in the global atorvastatin API market.

Regional Analysis

North America accounted for the largest market share of 40.64% in 2017, and the regional market is projected to register a CAGR of 3.10% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Chinese market is projected to exhibit the highest growth rate of 5.86% during the forecast period from 2018 to 2023.

The European market is estimated to exceed USD 1,31,094.04 thousand by 2023. High prevalence of hypercholesterolemia and mixed dyslipidemia are driving the growth of the Atorvastatin API market in the region. France is the major contributor to the growth of the regional market, followed by the UK.

Key Findings of the Study

The Global Atorvastatin API Market is projected to reach over USD 4,25,804.16 thousand by 2023 at 34% CAGR during the review period of 2018 to 2023.

North America accounted for the largest market share with the US being the major contributor to the growth of the market.

The hypercholesterolemia segment is projected to register the highest CAGR of 4.09% during the forecast period owing to the rising rate of hypercholesterolemia cases.

Key manufacturers are adopting geographic expansions, corporate acquisitions and product launches as growth strategies.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/atorvastatin-api-market-7885

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York, New York 10013,

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Comments

Post a Comment

Popular posts from this blog

Contraceptive Drugs Market Competitive landscape, future, growth till 2027

Image
  Contraceptive drugs Market is expected to register 6.8% CAGR during the forecast period, , with a market value of USD 16790.02 Million. Whereas in progestin-only contraceptives (POP) mainly just change the viscosity of mucus and thin the endometrium. The factors which drive the market of contraceptives drugs are increasing need of population controls and increasing prevalence of sexually transmitted diseases. According to report published by World Health Organization (WHO) in 2016, more than 1 million sexually transmitted infections (STIs) are acquired every day worldwide.   Additionally, report suggest that more than 500 million people are estimated to have genital infection with herpes simplex virus (HSV). Contraceptive drugs Market Growth is significant during forecast period. Contraceptives drugs refers to the medicines that are used to prevent unwanted pregnancy. Contraceptives drugs consists one or more synthetic female sex hormones, if they contain both estrogen an...
Read more

Retinal Implants Market Strategic Insights and key Business Influencing Factors

Image
  Retinal implants have proven its mettle as a breakthrough therapy in the treatment of visual impairment. The global retinal implants market is perceived to be growing at a recurring rate and is expected to reach high revenue figures in the coming years, as per the analysis of Market Research Future (MRFR). The global retinal implant market has been flourishing on account of the widespread prevalence of eye disorders across the globe. Growing cases of retinal disorders have induced high demand for retinal implants since they aid in the restoration of vision. Retinal implants have demonstrated significance for application in eye disorders which were once far-off impossible to achieve. The fact that these devices can be implanted with minimally invasive procedures has added to its popularity and driven the market. The rise in geriatric population is a crucial factor driving the growth of the retinal implant market. Owing to various health insufficiencies, the aging population is ...
Read more

Artificial Disc Replacement Market Strategic Insights and key Business Influencing Factors

Image
  Artificial disc replacement is the method used to treat back pain. It is also known as total disc replacement in which there is a replacement of degenerated intervertebral disc in spine column. This treatment is used to treat chronic and severe back pain and cervical pain. The major driving factors for global artificial disc replacement market are growing prevalence of degenerative spine condition because of increasing aging population across the globe, preference for minimal surgical procedure and many advantages over traditional spine fusion procedure. High cost of devices and lack of uniform reimbursement are major restraining factors for the market growth. Global Artificial Disc Replacement Market is expected to grow at a CAGR of 15% during forecasted period.On regional basis, global artificial disc replacement market is segmented into North America, Europe, Asia Pacific and Middle East and Africa. North America has a leading market for artificial disc replacement. Due to ...
Read more